Effect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease. [electronic resource]
Producer: 20100914Description: 421-7 p. digitalISSN:- 1563-5279
- Animals
- Antiparasitic Agents -- adverse effects
- Corpus Striatum -- drug effects
- Cyclin-Dependent Kinase 5 -- antagonists & inhibitors
- Disease Models, Animal
- Dopamine and cAMP-Regulated Phosphoprotein 32 -- metabolism
- Dyskinesia, Drug-Induced -- complications
- Female
- Levodopa -- adverse effects
- Male
- Oxidopamine
- Parkinsonian Disorders -- complications
- Phosphorylation -- drug effects
- Protein Kinase Inhibitors -- therapeutic use
- Purines -- therapeutic use
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Roscovitine
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.